Issue #1: Conivaptan
Added January 6, 2006 to the
Drug Monographs
Conivaptan (Vaprisol®)
Manufacturer: Astellas Pharma
FDA Approved Indications: Treatment of euvolemic hyponatremia (e.g. SIADH, hypothyroidism, adrenal insufficiency, pulmonary disorders, etc.) in hospitalized patients. It is not indicated for the treatment of patients with congestive heart failure.
Manufacturer: Astellas Pharma
FDA Approved Indications: Treatment of euvolemic hyponatremia (e.g. SIADH, hypothyroidism, adrenal insufficiency, pulmonary disorders, etc.) in hospitalized patients. It is not indicated for the treatment of patients with congestive heart failure.